Modulation of Doxorubicin-Induced Genotoxicity byAegle marmelosin Mouse Bone Marrow: A Micronucleus Study
Open Access
- 1 March 2007
- journal article
- Published by SAGE Publications in Integrative Cancer Therapies
- Vol. 6 (1), 42-53
- https://doi.org/10.1177/1534735406298302
Abstract
The effect of various concentrations of Aegle marmelos (AME) on the doxorubicin (DOX)-induced genotoxic effects in mice bone marrow was studied. Treatment of mice with different concentrations of DOX resulted in a dose-dependent elevation in the frequency of micronucleated polychromatic (MPCE) as well as normochromatic (MNCE) erythrocytes in mouse bone marrow. The frequencies of MPCE and MNCE increased with scoring time, and the greatest elevation for MPCE was observed at 48 hours post-DOX treatment, whereas a maximum increase in MNCE was observed at 72 hours post-DOX treatment. This increase in MPCE and MNCE was accompanied by a decline in the polychromatic erythrocytes–normochromatic erythrocytes (PCE/NCE) ratio, which showed a DOX-dose-dependent decline. Treatment of mice with 200, 250, 300, 350, and 400 mg/kg body weight of AME, orally once daily for 5 consecutive days before DOX treatment, significantly reduced the frequency of DOX-induced micronuclei accompanied by a significant elevation in the PCE/NCE ratio at all scoring times. The greatest protection against DOX-induced genotoxicity was observed at 350 mg/kg AME. The protection against DOX-induced genotoxicity by AME may be due to inhibition of free radicals and increased antioxidant status.Keywords
This publication has 69 references indexed in Scilit:
- Evaluation of the radioprotective effect of bael leaf (Aegle marmelos) extract in miceInternational Journal of Radiation Biology, 2004
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Micronuclei-induction and its correlation to cell survival in HeLa cells treated with different doses of adriamycinCancer Letters, 1996
- Antimutagenicity of eugenol in the rodent bone marrow micronucleus testMutation Research Letters, 1995
- Mutagenicity and carcinogenicity of topoisomerase-interactive agentsMutation research. Reviews in mutation research, 1994
- Inhibition of adriamycin-induced micronuclei by desferrioxamine in Swiss albino miceMutation Research Letters, 1993
- Effect of sampling time on chromosome aberration yield for 7 chemicals in Chinese hamster ovary cellsMutation research. Reviews in mutation research, 1992
- The present state and perspectives of micronucleus assay in radiation protection. A reviewInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1987
- The nature and repair of DNA lesions that lead to chromosomal aberrations induced by ionizing radiationsMutation research. Reviews in mutation research, 1986
- Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agentsBiochemical and Biophysical Research Communications, 1986